Benefits of hormone replacement therapy in postmenopausal women

Journal of the American Academy of Nurse Practitioners

Volumn 19, Issue 12, 2007, Pages 635-641

  Canderelli, Richard ^a   Leccesse, Lisa A ^a   Miller, Nancy L ^b  

^a MEMORIAL REGIONAL HOSPITAL   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Bone mineral density; Cardiovascular; Hormone replacement therapy; Hot flashes; Osteoporosis

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COLORECTAL TUMOR; DRUG EFFECT; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; LONGEVITY; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; NURSING; NURSING RESEARCH; PATIENT EDUCATION; PHYSIOLOGY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT OUTCOME; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; ESTROGEN REPLACEMENT THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LONGEVITY; NURSE PRACTITIONERS; NURSING RESEARCH; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT EDUCATION AS TOPIC; POSTMENOPAUSE; PRIMARY HEALTH CARE; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 36649036997     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2007.00269.x     Document Type: Article

References (20)

1. American College of Obstetricians and Gynecologists 2004). Frequently asked questions about hormone replacement therapy. Retrieved January 31, 2007, from http://acog.com/from_home/publications/press_releases/nr10-01-04.cfm
2. Anderson, G. L., Judd, H. L., Kaunitz, A. M., Barad, D. H., Beresford, S. A., Pettinger, M., et al 2003). Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: The women's health initiative randomized trial. JAMA, 290, 1739 1748.
3. Beers, M. H., et al Eds 2005). Menopause. In The Merck Manual of Geriatrics. Retrieved January 31, 2007, from http://www.merck.com/mrkshared/mmg/ sec14/ch119/ch119a.jsp
4. Brownley, K. A., Hinderliter, A. L., West, S. G., Grewen, K. M., Steege, J. F., Girder, S. S., et al 2003). Cardiovascular effects of six months of hormone replacement therapy versus placebo: Differences associated with years since menopause. American Journal of Obstetrics and Gynecology, 190 1052 1058.
5. Cauley, J. A., Robbins, J., Chen, Z., Cummings, S. R., Jackson, R. D., LaCroix, A. Z., et al 2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density: The women's health initiative randomized trial. JAMA, 290, 1729 1738.
6. Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, F. A., Ascensao, J., Rodabough, R. J 2004). Estrogen plus progestin and colorectal cancer in postmenopausal women. New England Journal of Medicine, 350, 991 1004.
7. Eden, J 2003). Progestins and breast cancer. American Journal of Obstetrics and Gynecology, 188, 1123 1131.
8. Ferrara, A., Karter, A. J., Ackerson, L. M., Liu, J. Y. Selby, J. V 2001). Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes. Diabetes Care, 24, 1144 1149.
9. Hackley, B. Rousseau, M. E 2004). Managing menopausal symptoms after the women's health initiative. Journal of Midwifery Women's Health, 49, 87 95.
10. Hall, L 2000). Taking charge of menopause. Retrieved January 31, 2007, from http://www.fda.gov/fdac/features/1999/699_meno.html
11. Hamdy, R. C 2002). Women's health initiative study. Southern Medical Journal, 95, 951 965.
12. Kerlikowske, K., Miglioretti, D. L., Ballard-Barbash, R., Weaver, D. L., Buist, D. S., Barlow, W. E., et al 2003). Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. Journal of Clinical Oncology, 21, 4314 4321.
13. Li, C. I., Malone, K. E., Porter, P. L., Weiss, N. S., Tang, M. C., Cushing-Haugen, K. L., et al 2003). Relationship between long durations and different regimens of hormone replacement therapy and risk of breast cancer. JAMA, 289, 3254 3263.
14. Michalowski, J. Nelson, N 2002). Summary of the evidence of the risks and benefits of postmenopausal use of hormones. Benchmark, 2 (8 2. Retrieved January 31, 2007, from http://www.cancer.gov/newscenter/benchmarks-vol2-issue8/ page2
15. National Center for Complimentary and Alternative Medicine 2005). Office of dietary supplements. Retrieved January 31, 2007, from http://od.nih.gov/ factsheets/BlackCohosh
16. National Center for Health Statistics 2006). Health, United States, 2006. Retrieved September 22, 2007, from http://nccam.nih.gov/health/blackcohosh
17. PRWEB 2005). A possible link between $24-billion-a-year "antacid" industry and the misery of menopause. Retrieved January 18, 2007, from http://www.emediawire.com/releases/2005/1/prweb196555.htm
18. Stearns, V., Ullmer, L., Lopez, J. F., Smith, Y., Isaacs, C. Hayes, D 2002). Hot flashes. Lancet, 360, 1851 1861.
19. Tammemagi, C. M., Nerenz, D., Neslund-Dudas, C., Feldkamp, C. Nathanson, D 2005). Comorbidity and survival disparities among black and white patients with breast cancer. JAMA, 294, 1765 1772.
20. Utian, W. H., Lederman, S. A., Williams, B. M., Vega, R. Y., Koltun, W. D. Leonard, T. W 2004). Relief of hot flashes with new plant derived 10-component synthetic conjugated estrogens. Obstetrics and Gynecologists, 103, 245 253.